Forbion
Finance · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gooimeer 2-35, Naarden, North Holland, 1...Phone Number
+31 356993000Website
www.forbion.comRevenue
$24.1 MillionIndustry
About Forbion
Forbion is a global life sciences venture capital firm headquartered in Naarden, the Netherlands, with additional offices in Munich, Germany, and Boston, USA. Originally established in 2000 as ABN AMRO Capital Life Sciences, the firm spun out as an independent entity in 2006 and has since built a strong track record of sourcing, building, and guiding biotech and biopharmaceutical companies from early stage through clinical development. Forbion invests across multiple fund strategies covering all stages of pharmaceutical drug development, with a primary focus on innovative therapeutics companies in Europe and North America. Beyond human health, the firm extends its biotechnology expertise through its BioEconomy fund strategy, which invests in companies developing sustainable solutions across food, agriculture, materials, and environmental technologies. Forbion operates a joint venture with BioGeneration Ventures for seed and early-stage investments, and is a signatory to the United NatiRead more
SIC Code 61,615NAICS Code 52,523Show moreForbion Org Chart
Compare Similar Companies to Forbion
Compare insights from companies similar to Forbion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Forbion Tech Stack
A closer look at the technologies used by Forbion
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Forbion
Sign Up For FreeTo access detailed company insights
Forbion is a global life sciences venture capital firm headquartered in Naarden, the Netherlands, with additional offices in Munich, Germany, and Boston, USA. Originally established in 2000 as ABN AMRO Capital Life Sciences, the firm spun out as an independent entity in 2006 and has since built a strong track record of sourcing, building, and guidi... Read More